BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 9637783)

  • 1. Regulation of vascular endothelial growth factor receptor-2 (Flk-1) expression in vascular endothelial cells.
    Pepper MS; Mandriota SJ
    Exp Cell Res; 1998 Jun; 241(2):414-25. PubMed ID: 9637783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular endothelial growth factor (VEGF)-C synergizes with basic fibroblast growth factor and VEGF in the induction of angiogenesis in vitro and alters endothelial cell extracellular proteolytic activity.
    Pepper MS; Mandriota SJ; Jeltsch M; Kumar V; Alitalo K
    J Cell Physiol; 1998 Dec; 177(3):439-52. PubMed ID: 9808152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eicosapentaenoic acid attenuates vascular endothelial growth factor-induced proliferation via inhibiting Flk-1 receptor expression in bovine carotid artery endothelial cells.
    Yang SP; Morita I; Murota SI
    J Cell Physiol; 1998 Aug; 176(2):342-9. PubMed ID: 9648921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular endothelial growth factor (VEGF) receptor-2 antagonists inhibit VEGF- and basic fibroblast growth factor-induced angiogenesis in vivo and in vitro.
    Tille JC; Wood J; Mandriota SJ; Schnell C; Ferrari S; Mestan J; Zhu Z; Witte L; Pepper MS
    J Pharmacol Exp Ther; 2001 Dec; 299(3):1073-85. PubMed ID: 11714897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic effects of vascular endothelial growth factor and basic fibroblast growth factor on the proliferation and cord formation of bovine capillary endothelial cells within collagen gels.
    Goto F; Goto K; Weindel K; Folkman J
    Lab Invest; 1993 Nov; 69(5):508-17. PubMed ID: 8246443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic effect of basic fibroblast growth factor and vascular endothelial growth factor in murine hepatocellular carcinoma.
    Yoshiji H; Kuriyama S; Yoshii J; Ikenaka Y; Noguchi R; Hicklin DJ; Huber J; Nakatani T; Tsujinoue H; Yanase K; Imazu H; Fukui H
    Hepatology; 2002 Apr; 35(4):834-42. PubMed ID: 11915029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic induction of t-PA by vascular endothelial growth factor and basic fibroblast growth factor and localization of t-PA to Weibel-Palade bodies in bovine microvascular endothelial cells.
    Pepper MS; Rosnoblet C; Di Sanza C; Kruithof EK
    Thromb Haemost; 2001 Aug; 86(2):702-9. PubMed ID: 11522025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic effect of hyaluronan oligosaccharides and vascular endothelial growth factor on angiogenesis in vitro.
    Montesano R; Kumar S; Orci L; Pepper MS
    Lab Invest; 1996 Aug; 75(2):249-62. PubMed ID: 8765325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular endothelial growth factor-toxin conjugate specifically inhibits KDR/flk-1-positive endothelial cell proliferation in vitro and angiogenesis in vivo.
    Ramakrishnan S; Olson TA; Bautch VL; Mohanraj D
    Cancer Res; 1996 Mar; 56(6):1324-30. PubMed ID: 8640821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptides encoded by exon 6 of VEGF inhibit endothelial cell biological responses and angiogenesis induced by VEGF.
    Jia H; Jezequel S; Löhr M; Shaikh S; Davis D; Soker S; Selwood D; Zachary I
    Biochem Biophys Res Commun; 2001 Apr; 283(1):164-73. PubMed ID: 11322784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myocardial VEGF expression after cardiopulmonary bypass and cardioplegia.
    Tofukuji M; Metais C; Li J; Franklin A; Simons M; Sellke FW
    Circulation; 1998 Nov; 98(19 Suppl):II242-6; discussion II247-8. PubMed ID: 9852909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular endothelial growth factor and basic fibroblast growth factor present in Kaposi's sarcoma (KS) are induced by inflammatory cytokines and synergize to promote vascular permeability and KS lesion development.
    Samaniego F; Markham PD; Gendelman R; Watanabe Y; Kao V; Kowalski K; Sonnabend JA; Pintus A; Gallo RC; Ensoli B
    Am J Pathol; 1998 Jun; 152(6):1433-43. PubMed ID: 9626048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular endothelial growth factor (VEGF) and VEGF receptor 2 (flk-1) are expressed during vasculogenesis and vascular differentiation in the quail embryo.
    Flamme I; Breier G; Risau W
    Dev Biol; 1995 Jun; 169(2):699-712. PubMed ID: 7781909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The coronary endothelium: a target for vascular endothelial growth factor. Human coronary artery endothelial cells express functional receptors for vascular endothelial growth factor in vitro and in vivo.
    Kranz A; Mayr U; Frank H; Waltenberger J
    Lab Invest; 1999 Aug; 79(8):985-91. PubMed ID: 10462036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostaglandin E2 induces vascular endothelial growth factor and basic fibroblast growth factor mRNA expression in cultured rat Müller cells.
    Cheng T; Cao W; Wen R; Steinberg RH; LaVail MM
    Invest Ophthalmol Vis Sci; 1998 Mar; 39(3):581-91. PubMed ID: 9501870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 17 Beta-estradiol increases VEGF receptor-2 and promotes DNA synthesis in retinal microvascular endothelial cells.
    Suzuma I; Mandai M; Takagi H; Suzuma K; Otani A; Oh H; Kobayashi K; Honda Y
    Invest Ophthalmol Vis Sci; 1999 Aug; 40(9):2122-9. PubMed ID: 10440269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of KDR expression in bovine arterial endothelial cells by thrombin: involvement of nitric oxide.
    Wang J; Morita I; Onodera M; Murota SI
    J Cell Physiol; 2002 Feb; 190(2):238-50. PubMed ID: 11807828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of tecogalan sodium on angiogenesis in vitro by choroidal endothelial cells.
    Sakamoto T; Ishibashi T; Kimura H; Yoshikawa H; Spee C; Harris MS; Hinton DR; Ryan SJ
    Invest Ophthalmol Vis Sci; 1995 May; 36(6):1076-83. PubMed ID: 7537258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment for malignant pleural effusion of human lung adenocarcinoma by inhibition of vascular endothelial growth factor receptor tyrosine kinase phosphorylation.
    Yano S; Herbst RS; Shinohara H; Knighton B; Bucana CD; Killion JJ; Wood J; Fidler IJ
    Clin Cancer Res; 2000 Mar; 6(3):957-65. PubMed ID: 10741721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular endothelial growth factor acts as a pericyte mitogen under hypoxic conditions.
    Yamagishi S; Yonekura H; Yamamoto Y; Fujimori H; Sakurai S; Tanaka N; Yamamoto H
    Lab Invest; 1999 Apr; 79(4):501-9. PubMed ID: 10212003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.